Award
Definitive Contract #75F40126C00094
University of Maryland Awarded Multi-Year AI Imaging Contract for Pulmonary Embolism
Buyer
Food and Drug Administration
Award Amount
$749,621.00
Ceiling
$749,621.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2027
Identifier
75F40126C00094
NAICS
334516
This definitive contract has been awarded to the University of Maryland, Baltimore, a renowned academic institution specializing in medical research and healthcare innovation. The contract focuses on the development and implementation of a real-world evidence and localized artificial intelligence (AI) imaging testbed aimed at enhancing the diagnosis and analysis of pulmonary embolism, a critical medical condition. This project is significant for advancing diagnostic accuracy and improving patient outcomes through the application of sophisticated AI technologies. The scope of work includes the creation and validation of AI-driven imaging tools designed to efficiently analyze pulmonary embolism cases. Awarded through a competitive bidding process, this multi-year contract represents a substantial commitment and investment in cutting-edge healthcare technology within the public health sector. The performance of the contract is scheduled to take place at the University’s Baltimore facilities over a one-year period.
Description
EO 14398 BAA CONTRACT REAL AIPE REAL-WORLD EVIDENCE AND LOCALIZED AI IMAGING TESTBED FOR PULMONARY EMBOLISM